Skip to content
value.today

Orthalign Inc.

Formerly Vitruvian Orthopaedics, Inc.

Total raised
$46 M
6 rounds on record
Latest round
$11 M
Aug 2020
First round on record
Jan 2010
Today
Private
No later event on record

Funding rounds

6 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Orthalign Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Aug 2020$11 MNo. 6$10 to $50 million

Orthalign Inc.: Raise no. 6, Aug 2020

Investors in this round

6 investors had bought by the notice of Sep 2, 2020: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$11 M of $18 M offered; $7 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David S. Smith · Executive Officer
  • Eric Timko · Executive Officer, Director
  • Mike S. Bushack · Executive Officer
  • Carter Ronald McNabb · Director
  • Christopher Ronald Martin · Director
  • D. Ronald Yagoda · Director
  • Gary Ronald Henley · Director
  • Wayne Ronald Wallace · Director
  • William Ronald Hanna · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by David S. Smith, Secretary. Source: SEC Form D, newest notice filed Sep 2, 2020. Read the notice at the SEC.

equitySEC
Dec 2019$3 MNo. 5$2 to $10 million

Orthalign Inc.: Raise no. 5, Dec 2019

Investors in this round

6 investors had bought by the notice of Jan 9, 2020: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $8 M offered; $5 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, other: Series E Preferred Stock, including the shares of Common Stock issuable upon conversion of the Series E Preferred Stock.
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David S. Smith · Executive Officer
  • Eric Timko · Executive Officer, Director
  • Mike S. Bushack · Executive Officer
  • Carter Ronald McNabb · Director
  • Christopher Ronald Martin · Director
  • D. Ronald Yagoda · Director
  • Gary Ronald Henley · Director
  • Wayne Ronald Wallace · Director
  • William Ronald Hanna · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by David S. Smith, Secretary. Source: SEC Form D, newest notice filed Jan 9, 2020. Read the notice at the SEC.

equitySEC
Aug 2017$8 MNo. 4$2 to $10 million

Orthalign Inc.: Raise no. 4, Aug 2017

Investors in this round

6 investors had bought by the notice of Aug 28, 2017: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$8 M of $10 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, other: Series D Preferred Stock, including the shares of Common Stock issuable upon conversion of the Series D Preferred Stock.
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David S. Smith · Executive Officer
  • Eric Timko · Executive Officer, Director
  • Carter Ronald McNabb · Director
  • Christopher Ronald Martin · Director
  • D. Ronald Yagoda · Director
  • Gary Ronald Henley · Director
  • Wayne Ronald Wallace · Director
  • William Ronald Hanna · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by David S. Smith, Secretary. Source: SEC Form D, newest notice filed Aug 28, 2017. Read the notice at the SEC.

equitySEC
Nov 2014$15 MNo. 3$10 to $50 million

Orthalign Inc.: Raise no. 3, Nov 2014

Investors in this round

15 investors had bought by the notice of Nov 14, 2014: 15 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$15 M of $18 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them, other: Series C Preferred Stock, including the shares of Common Stock issuable upon conversion of the Series C Preferred Stock.
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • William E. Maya · Executive Officer, Director
  • Carter Ronald McNabb · Director
  • Christopher Ronald Martin · Director
  • D. Ronald Yagoda · Director
  • Wayne Ronald Wallace · Director
  • William Ronald Hanna · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by William E. Maya, Ceo. Source: SEC Form D, newest notice filed Nov 14, 2014. Read the notice at the SEC.

equity, optionsSEC
Nov 2010$4 MNo. 2$2 to $10 million

Orthalign Inc.: Raise no. 2, Nov 2010

Investors in this round

14 investors had bought by the notice of Dec 8, 2010: 14 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $4 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, other: Series B Preferred Stock, including the shares of Common Stock issuable upon conversion of the Series B Preferred Stock
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Edwin F. Scheetz · Executive Officer, Director
  • Pieter Wolters · Executive Officer, Director
  • Christopher Ronald Martin · Director
  • D. Ronald Yagoda · Director
  • Sharon Ronald Stevenson · Director
  • William Ronald Hanna · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Pieter Wolters, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Dec 8, 2010. Read the notice at the SEC.

equitySEC
Jan 2010$5 MNo. 1$2 to $10 million

Orthalign Inc.: Raise no. 1, Jan 2010

Investors in this round

6 investors had bought by the notice of Feb 8, 2010: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $5 M offered
Smallest investment taken
no minimum stated
What was sold
equity, other: Series A-2 Preferred Stock, including the shares of Common Stock issuable upon conversion of the Series A-2 Preferred Stock
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Edwin F. Scheetz · Executive Officer, Director
  • Pieter Wolters · Executive Officer, Director
  • Christopher Ron Martin · Director
  • D. Ron Yagoda · Director
  • Sharon Ron Stevenson · Director
  • William Ron Hanna · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Pieter Wolters, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Feb 8, 2010. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Orthalign Inc. chose not to state its revenue in its newest notice of a funding round (Sep 2020).

    SEC Form D · Sep 2020

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Sep 2020

That is all the official record says: Orthalign Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Orthalign Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 6 rounds above had up to 15 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Orthalign Inc.
NameRoleNamed in
David S. SmithExecutive officerSep 2020
Eric TimkoExecutive officerSep 2020
Mike S. BushackExecutive officerSep 2020
William E. MayaExecutive officerNov 2014
Edwin F. ScheetzExecutive officerDec 2010
Pieter WoltersExecutive officerDec 2010
Carter Ronald McNabbDirectorSep 2020
Christopher Ronald MartinDirectorSep 2020
D. Ronald YagodaDirectorSep 2020
Eric TimkoDirectorSep 2020
Gary Ronald HenleyDirectorSep 2020
Wayne Ronald WallaceDirectorSep 2020
William Ronald HannaDirectorSep 2020
William E. MayaDirectorNov 2014
Edwin F. ScheetzDirectorDec 2010
Pieter WoltersDirectorDec 2010
Sharon Ronald StevensonDirectorDec 2010
Christopher Ron MartinDirectorFeb 2010
D. Ron YagodaDirectorFeb 2010
Sharon Ron StevensonDirectorFeb 2010
William Ron HannaDirectorFeb 2010